ESMO 2017 Press Release: ESMO Award goes to Miguel Martin

  • Date: 20 Jul 2017

LUGANO, Switzerland, 20 July 2017 – The European Society for Medical Oncology (ESMO) has bestowed its prestigious 2017 ESMO Award on breast cancer expert Miguel Martin, medical oncologist in Madrid, Spain.

The award will be presented during the opening session at the ESMO 2017 Congress (8-12 September, Madrid, Spain).

The ESMO award was created in 1985 to recognise an ESMO member who has made outstanding contributions to the development of medical oncology as a specialty within the oncology community.

Martin is President of the Spanish Society of Medical Oncology (SEOM), Professor of Medicine at the Complutense University, and head of the Medical Oncology Service at the Hospital General Universitario Gregorio Marañon, in Madrid.

Since 2001, he has served on the Board of Directors and the Scientific Steering Committee of the Translational Research in Oncology (TRIO) group, an international not-for-profit clinical research organisation involving 45 different countries.

In 1995, Martin created GEICAM (the Spanish Group for Breast Cancer Research), a network of more than 180 Spanish institutions, which has carried out upwards of 130 clinical, translational and epidemiological studies in the field of breast cancer.

Calling the award “an immense honour”, and “the highest recognition I have ever received in my career”, Martin said he considers the ESMO Award a shared honour: “It is recognition not only of my personal contribution to research in medical oncology and breast cancer, but also the work of SEOM in general, and the members of GEICAM, in particular. My interpretation is that ESMO is actually awarding our collective work that is often also a collaborative effort with other European and American groups.”

On behalf of the ESMO Fellowship and Award Committee, Christoph Zielinski said, “Miguel Martin is an international global leader in widening our biologic understanding of breast cancer. He is recognised for his highly respected and important academic contributions in the field of breast cancer treatment, as well as his design and implementation of an abundance of important clinical trials. His work has deepened our understanding of ways to optimise breast cancer treatment and define new treatment paradigms.”

Martin said: “The ESMO Award is an enormous stimulus not only for me, but for my Spanish colleagues as well. The award will certainly help to encourage young Spanish oncologists in pursuing their academic careers in close collaboration with their ESMO colleagues.”

He noted his special gratitude to Professor Eduardo Diaz-Rubio, one of the founding fathers of medical oncology in Spain “and the person who introduced me into the then incipient field of medical oncology. Without his clever vision, medical oncology in Spain would not be the strong medical speciality it is today. I am also deeply indebted to Dr. Dennis Slamon, from the Universty of California, Los Angeles, the person who has had the greatest influence in my understanding of cancer biology and research.”

 

-END-

Notes to Editors

References

The ESMO Award will be presented to Miguel Martin during the Opening Session of the ESMO 2017 Congress on 8 September 2017, 12:00-13:20 (CEST) in the Madrid Auditorium of the Ifema, Madrid.

Info on all ESMO awards is available  here

About the European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With more than 16,000 members representing oncology professionals from over 130 countries worldwide, ESMO is the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evolving professional environment.